| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 257.6 | 218.0 | 226.4 |
| Other income | 16.8 | 17.8 | 17.9 |
| Total income | 274.4 | 235.8 | 244.4 |
| Profit before exceptional items & tax | 28.9 | 26.0 | 17.7 |
| Exceptional items | 0.0 | 3.5 | 0.0 |
| Profit before tax | 28.9 | 29.5 | 17.7 |
| Net profit | 21.3 | 21.8 | 13.0 |
| Operating margin | 10.5% | 12.5% | 7.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +63.80% |
|---|---|
| Net profit, quarter on quarter | -2.30% |
| Revenue, year on year | +13.80% |
| Operating profit, year on year | +6150.00% |
| Operating profit, quarter on quarter | +47.60% |
BSE results filing, NSE: TTKHLTCARE. Figures extracted from the filing.
TTK Healthcare Ltd: key numbers
- Share price
- ₹1,045.60
- Market cap
- ₹1,477 Cr
- Revenue (annual)
- ₹857.3 Cr
- Net profit (annual)
- ₹65.68 Cr
- P/E (TTM)
- 20.0×Sector 22.8×
- Promoter holding
- 74.56%+0.00% QoQ
- FII holding
- 1.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TTK Healthcare Ltd
All →TTK Healthcare Merger & Restructuring Worth ₹256 Cr
TTK Healthcare completed the sale of its "EVA" and "Good Home" brands to Wipro Enterprises. The company received Rs. 256 crore in cash consideration.
- Value
- ₹256.0 Cr
TTK Healthcare Other Announcement
TTK Healthcare Limited has appointed M/s. R V K & Co., Chartered Accountants, as the Company's Tax Auditor. The appointment is for a three-year term covering FY 2025-26 to 2027-28.
- Execution
- 3 years
TTK Healthcare Management Change
TTK Healthcare Ltd announced that its tax auditor, M/s Aiyar & Co., resigned effective August 26, 2026. The auditor cited eligibility issues regarding their peer review certificate.
TTK Healthcare Board Meeting Date
TTK Healthcare has scheduled a board meeting for August 06, 2026, to approve the company's unaudited financial results for the first quarter ended June 30, 2026.
TTK Healthcare Management Change
TTK Healthcare Limited announced the re-appointment of Mr. Thiruvallur Thattai Raghunathan as Executive Director. The appointment is effective from November 1, 2026, for a term of 60 months.
TTK Healthcare Annual General Meeting
TTK Healthcare Ltd held its 68th Annual General Meeting via video conferencing. The meeting included the declaration of a dividend of Rs.10.00 per share.